| ADMA | Asymmetric dimethylarginine |
| ADM | Adrenomedullin |
| AHA | American Heart Association |
| ALT | Alanine aminotransferase |
| ANP | Atrial natriuretic peptide |
| Apo-B | Apolipoprotein B |
| AST | Aspartate aminotransferase |
| BCAAs | Branched-chain amino acids |
| BCKAs | Branched-chain α-keto acids |
| BNP | Brain natriuretic peptide |
| CPK | Creatine phosphokinase |
| CHD | Coronary heart disease |
| CVD | Cardiovascular diseases |
| C2, C8, C14:1 | Acylcarnitines |
| Cer(d18:1/16:0) | Sphingolipids/Ceramides |
| ET-1 | Endothelin-1 |
| ICAM-1 | Intercellular adhesion molecule-1 |
| FPA | Fibrinopeptide A |
| GDF-15 | Growth and differentiation factor |
| GC-MS | Gas Chromatography–Mass Spectrometry |
| HDMB | Human Database of Metabolomics Biomarkers |
| HDL | High-density lipoprotein |
| HPLC | High-performance liquid chromatography |
| hs-cTnT | High-sensitive troponin T |
| hs-cTnI | High-sensitive troponin I |
| LDH | Lactate dehydrogenase |
| LDL | Low-density lipoprotein |
| MS | Mass spectrometry |
| MACE | Major Adverse Cardiac Events |
| LC-MS/MS | Liquid Chromatography–Tandem Mass Spectrometry |
| LPC, PE, SM | Lipids/Phospholipids |
| NO | Nitric oxide |
| NT-proBNP | Natriuretic peptide |
| NMR | Nuclear magnetic resonance |
| PICP | Type I procollagen propeptide |
| t-PA | Tissue plasminogen activator |
| RBP4 | Retinol-binding protein 4 |
| ST2 | Growth stimulation factor |
| TIMP-1 | Tissue inhibitors of matrix metalloproteinases 1 |
| TIMP-2 | Tissue inhibitors of matrix metalloproteinases 2 |
| TNF-α | Tumor necrosis factor alpha |
| sTM | Thrombomodulin |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VWF | Von Willebrand factor |
| WHO | World Health Organization |
| 12-HETE, 15-HETE | Oxylipins |